Highlights Neuronetics, Inc.

Equities

STIM

US64131A1051

Delayed Nasdaq Other stock markets 01:46:16 2024-04-29 pm EDT			5-day change	1st Jan Change
3.54 ^USD	+1.44%		-5.34%	+22.07%

Apr. 10	Neuronetics, Inc. Announces the Publication of Significant Clinical Findings in Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation	CI
Mar. 28	Neuronetics, Inc. Announces John K. Bakewell, Joseph H. Capper and Dr. Wilfred E. Jaeger Not Stand for Reelection to the Board	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Neuronetics, Inc. Announces the Publication of Significant Clinical Findings in Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation	Apr. 10	CI
Neuronetics Shares Climb 15% After FDA Cleared Depression Treatment for Adolescents Aged 15 to 21	Mar. 25	DJ
Neuronetics Gets US FDA Clearance for Treatment of Adolescents with Depression; Shares Rise	Mar. 25	MT
Neuronetics, Inc. Announces Clearance from the U.S. Food and Drug Administration for NeuroStar Advanced Therapy	Mar. 25	CI
Neuronetics, Inc. Announces 5-Year Exclusive Partnership with Transformations Care Network	Mar. 07	CI
Earnings Flash (STIM) NEURONETICS Reports Q4 Revenue $20.3M	Mar. 05	MT
Neuronetics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 05	CI
Neuronetics, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	Mar. 05	CI
North American Morning Briefing : S&P 500 Futures -2-	Mar. 05	DJ
Neuronetics Launches Latest Evolution in Its Trakstar® Patient Data Management System	Feb. 12	CI
Neuronetics, Inc. Revises Earnings Guidance for the Fourth Quarter and Full Year of 2023	Jan. 08	CI
Neuronetics Receives 510(K) Clearance for Neurosite Coil Placement Accessory	Dec. 18	CI
Neuronetics, Inc. Elevates Depression Treatment with Cutting-Edge Technology Advancements	Nov. 13	CI
Earnings Flash (STIM) NEURONETICS Reports Q3 Revenue $17.9M	Nov. 07	MT
Neuronetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Neuronetics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023	Nov. 07	CI
Neuronetics, Inc. Announces the Launch of the NeuroStar Voices Portal	23-09-12	CI
Neuronetics, Inc. Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar Platform	23-08-14	CI
Earnings Flash (STIM) NEURONETICS Reports Q2 Revenue $17.6M, vs. Street Est of $17.5M	23-08-08	MT
Neuronetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Neuronetics, Inc.

Equities

STIM

US64131A1051

Highlights

Filters